The molecular basis of human retinal and vitreoretinal diseases

W Berger, B Kloeckener-Gruissem… - Progress in retinal and eye …, 2010 - Elsevier
During the last two to three decades, a large body of work has revealed the molecular basis
of many human disorders, including retinal and vitreoretinal degenerations and …

Splicing in disease: disruption of the splicing code and the decoding machinery

GS Wang, TA Cooper - Nature Reviews Genetics, 2007 - nature.com
Human genes contain a dense array of diverse cis-acting elements that make up a code
required for the expression of correctly spliced mRNAs. Alternative splicing generates a …

Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa

A Buskin, L Zhu, V Chichagova, B Basu… - Nature …, 2018 - nature.com
Mutations in pre-mRNA processing factors (PRPFs) cause autosomal-dominant retinitis
pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed genes cause non …

Pre-mRNA splicing and human disease

NA Faustino, TA Cooper - Genes & development, 2003 - genesdev.cshlp.org
The precision and complexity of intron removal during pre-mRNA splicing still amazes even
26 years after the discovery that the coding information of metazoan genes is interrupted by …

Emerging roles of spliceosome in cancer and immunity

H Yang, B Beutler, D Zhang - Protein & Cell, 2022 - academic.oup.com
Precursor messenger RNA (pre-mRNA) splicing is catalyzed by an intricate
ribonucleoprotein complex called the spliceosome. Although the spliceosome is considered …

Comprehensive proteomic analysis of the human spliceosome

Z Zhou, LJ Licklider, SP Gygi, R Reed - Nature, 2002 - nature.com
The precise excision of introns from pre-messenger RNA is performed by the spliceosome, a
macromolecular machine containing five small nuclear RNAs and numerous proteins. Much …

Alternative splicing in disease and therapy

MA Garcia-Blanco, AP Baraniak, EL Lasda - Nature biotechnology, 2004 - nature.com
Alternative splicing is the major source of proteome diversity in humans and thus is highly
relevant to disease and therapy. For example, recent work suggests that the long-sought …

A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered …

DS Hong, R Kurzrock, A Naing, JJ Wheler… - Investigational new …, 2014 - Springer
The aim of this study was to determine the maximum tolerated dose, dose-limiting toxicities,
and pharmacokinetic profile of E7107 in patients with advanced solid tumors. Patients in this …

Prp8 protein: at the heart of the spliceosome

RJ Grainger, JD Beggs - Rna, 2005 - rnajournal.cshlp.org
Pre-messenger RNA (pre-mRNA) splicing is a central step in gene expression. Lying
between transcription and protein synthesis, pre-mRNA splicing removes sequences …

Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families

LS Sullivan, SJ Bowne, DG Birch… - … & visual science, 2006 - iovs.arvojournals.org
purpose. To survey families with clinical evidence of autosomal dominant retinitis
pigmentosa (adRP) for mutations in genes known to cause adRP. methods. Two hundred …